Nebenwirkungen · Intuniv
Intuniv 1 mg prolonged-release tablets Intuniv 2 mg prolonged-release tablets Intuniv 3 mg prolonged-release tablets Intuniv 4 mg prolonged-release tablets · Abschnitt 4.8 · PDF-Seite 10
HOS-131103 · Präparat HOS-097005
The most frequently reported adverse reactions include somnolence (40.6%), headache (27.4%), fatigue (18.1%), abdominal pain upper (12.0%), and sedation (10.2%). The most serious adverse reactions commonly reported include hypotension (3.2%), weight increase (2.9%), bradycardia (1.5%) and syncope (0.7%). The adverse reactions somnolence and sedation occurred predominantly at the start of treatment and may typically last for 2-3 weeks and longer in some cases.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-10-13T16:10:00Z · SHA-256 b225f42374a72478897a7ffe5fe45a28ed820ad0d048d0ca17875afae195379b · Passage 061789fb969ec5c3bc44aa2e6a8dd36d654caa6334017d9852a0897244080346 · Zeichen 31–494 im Abschnitt